FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo
BRUSSELS: The European Commission said on Thursday it had concluded preliminary talks with U.S. pharmaceutical company Johnson & Johnson for an advance purchase deal of a potential COVID-19 vaccine the company is developing.
The EU executive arm said this could pave the way for the signing of a contract that would allow EU countries to buy the vaccines or donate to developing countries.
